Valuation: AVRA Medical Robotics, Inc.

Market Cap 750M 658M 610M 561M 1.06B 72.28B 1.07B 7.27B 2.85B 35.42B 2.82B 2.76B 122B P/E 2026 *
-62.5x
P/E 2027 * -62.5x
Enterprise Value 750M 658M 610M 561M 1.06B 72.28B 1.07B 7.27B 2.85B 35.42B 2.82B 2.76B 122B EV / Sales 2026 *
12.6x
EV / Sales 2027 * 9.98x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
Change 5-day change 1-year change 3-year change Capi.($)
-3.50%-.--% - - 51.19M
-0.18%-4.18%-1.02%+2.10% 48.71B
+1.61%-0.91%+377.07%+584.68% 38.35B
+2.61%+3.96%+9.16%+61.36% 34.53B
-1.12%-2.99%+26.84%-11.67% 34.03B
-0.58%-2.00%-0.07%+31.08% 26.77B
+1.37%-3.90% - - 15.64B
+0.71%-0.84%+72.13%+116.76% 15.08B
-2.03%+0.23%+13.53%+15.87% 14.18B
+0.26%-0.80%+19.33%-32.25% 12.73B
Average -0.04%-1.04%+64.62%+95.99% 26.67B
Weighted average by Cap. +0.48%-1.36%+76.50%+118.79%

Financials

2026 *2027 *
Net sales 59.4M 52.06M 48.24M 44.4M 83.73M 5.72B 84.74M 576M 225M 2.8B 223M 218M 9.68B 75.2M 65.91M 61.07M 56.21M 106M 7.24B 107M 729M 285M 3.55B 282M 276M 12.26B
Net income -12M -10.52M -9.75M -8.97M -16.91M -1.16B -17.12M -116M -45.52M -566M -45.05M -44.08M -1.96B -14M -12.27M -11.37M -10.46M -19.73M -1.35B -19.97M -136M -53.1M -661M -52.55M -51.42M -2.28B
Net Debt - -
Logo AVRA Medical Robotics, Inc.
SS Innovations International, Inc., formerly AVRA Medical Robotics, Inc, is a medical robotics company. The Company is engaged in developing a fully autonomous medical robotic system using its software, which integrates artificial intelligence (AI) and deep learning, or machine learning (DL). By using an AI and DL-enhanced software program, it is creating an intelligent robotic system that robotizes a range of medical procedures. It is developing a treatment-independent autonomous robotics system utilizing its AI-driven precision guidance system, applicable to a variety of minimally and non-invasive procedures, with a focus on skin resurfacing aesthetic procedures. Its medical robotic system is being developed to deliver skin resurfacing treatments, such as micro-needling and laser therapies. Its autonomous medical robotics system is being developed to be compatible with available surgical tools and end-effectors, enabling it to enter the micro-needling and laser solutions market.
Employees
-